Paeds SAQs · fetal-neonatal-and-perinatal
Fetal growth restriction and small-for-gestational-age infant — formative SAQs
Formative SAQs.
On this page
Study tools
Target exams
RACP General PaediatricsRACP DCEMRCPCH Clinical
Prompt
Fetal growth restriction and small-for-gestational-age infant
SAQ 1 (10)
A 37-week male infant is born weighing 2150 g (below the 3rd centile for gestation and sex on an INTERGROWTH-21st chart). The pregnancy was complicated by pre-eclampsia; antenatal umbilical artery Doppler showed absent end-diastolic flow. He is wasted, with a disproportionately large head and loose dry skin. At two hours of age he is cool (35.6 °C) and a pre-feed glucose is low despite a breastfeed. [1] [4]
- Define the key terms small-for-gestational-age (SGA) and fetal growth restriction (FGR), and explain why they overlap but are not synonymous. (3) [1]
- Outline the four neonatal complications you should most actively anticipate and pre-empt in this infant. (3) [8]
- Describe your stepwise management of his hypoglycaemia. (4) [8]
Model answer
- SGA is a size descriptor: birthweight or estimated fetal weight below the 10th centile (severe below the 3rd) for gestation and sex on a standard chart. FGR is a pathological failure to reach genetic growth potential, usually from placental insufficiency. They overlap because many FGR infants are SGA, but a constitutionally small infant is healthy and not growth-restricted, and a growth-restricted fetus may not yet be below the 10th centile if its velocity has only just fallen. [1] [2]
- The four complications to pre-empt are hypothermia (low fat stores), hypoglycaemia (depleted glycogen), polycythaemia/hyperviscosity (chronic hypoxia-driven erythropoietin) and feeding difficulty (starved gut). [8]
- Warm the infant and feed within the first hour; recheck pre-feed glucose on a schedule; if low after a feed, give buccal 40% dextrose gel (200 mg/kg) with a feed and recheck; escalate to an intravenous 10% dextrose bolus then an escalating infusion for persistent hypoglycaemia; involve senior/neonatal team and treat any underlying cause. [8]
References8ShowHide
- [1]Gordijn SJ Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound in Obstetrics & Gynecology, 2016.PMID 26909664
- [2]Figueras F Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagnosis and Therapy, 2014.PMID 24457811
- [3]Villar J International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet, 2014.PMID 25209487
- [4]Lees CC Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound in Obstetrics & Gynecology, 2013.PMID 24078432
- [5]Lees CC 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet, 2015.PMID 25747582
- [6]Crispi F Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention from birth. American Journal of Obstetrics and Gynecology, 2018.PMID 29422215
- [7]Victora CG, Villar J, Barros FC, et al. Anthropometric characterization of impaired fetal growth: risk factors for and prognosis of newborns with stunting or wasting. JAMA Pediatrics, 2015.PMID 26147058
- [8]McKinlay CJ Neonatal glycemia and neurodevelopmental outcomes at 2 years. New England Journal of Medicine, 2015.PMID 26465984